Extracellular histidine residues identify common structural determinants in the copper/zinc P2X2 receptor modulation.
To assess the mechanism of P2X2 receptor modulation by transition metals, the cDNA for the wild-type receptor was injected to Xenopus laevis oocytes and examined 48-72 h later by the two-electrode voltage-clamp technique. Copper was the most potent of the trace metals examined; at 10 microm it evoked a 25-fold potentiation of the 10 microm ATP-gated currents. Zinc, nickel or mercury required 10-fold larger concentrations to cause comparable potentiations, while palladium, cobalt or cadmium averaged only 12- and 3-fold potentiations, respectively. Platinum was inactive. The non-additive effect of copper and zinc at 10-100 microm suggests a common site of action; these metals also shifted to the left the ATP concentration-response curves. To define residues necessary for trace metal modulation, alanines were singly substituted for each of the nine histidines in the extracellular domain of the rat P2X2 receptor. The H120A and H213A mutants were resistant to the modulator action of copper, zinc and other metals with the exception of mercury. Mutant H192A showed a reduction but not an abrogation of the copper or zinc potentiation. H245A showed less affinity for copper while this mutant flattened the zinc-induced potentiation. Mutant H319A reduced the copper but not the zinc-induced potentiation. In contrast, mutants H125A, H146A, H152A and H174A conserved the wild-type receptor sensitivity to trace metal modulation. We propose that His120, His192, His213 and His245 form part of a common allosteric metal-binding site of the P2X2 receptor, which for the specific coordination of copper, but not zinc, additionally involves His319.
Lorca
Ramón A
RA
Departmentos de Fisiología, Centro de Regulacion Celular y Patologia J.V. Luco, Instituto MIFAB, Faculty de Ciencias biologicas, Pontifica Universidad Catolica de Chile, Santiago, Chile.
Coddou
Claudio
C
Gazitúa
M Consuelo
MC
Bull
Paulina
P
Arredondo
Cristián
C
Huidobro-Toro
J Pablo
JP
D000255:Adenosine Triphosphate / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D003300:Copper / Q000494:pharmacology*; D004357:Drug Synergism; D004594:Electrophysiology; D005110:Extracellular Space / Q000187:drug effects / Q000378:metabolism; D006639:Histidine / Q000737:chemistry*; D006863:Hydrogen-Ion Concentration; D008564:Membrane Potentials / Q000502:physiology; D016297:Mutagenesis, Site-Directed; D009865:Oocytes / Q000378:metabolism; D018408:Patch-Clamp Techniques; D012313:RNA; D051381:Rats; D018048:Receptors, Purinergic P2 / Q000737:chemistry* / Q000187:drug effects / Q000235:genetics; D058476:Receptors, Purinergic P2X2; D014131:Trace Elements / Q000494:pharmacology; D014982:Xenopus laevis; D015032:Zinc / Q000494:pharmacology*
C546403:P2rx2 protein, rat; C034477:RNA primers; D018048:Receptors, Purinergic P2; D058476:Receptors, Purinergic P2X2; D014131:Trace Elements; D006639:Histidine; D012313:RNA; D003300:Copper; D000255:Adenosine Triphosphate; D015032:Zinc